Cargando…

Dysfunction of the CNS-Heart Axis in Mouse Models of Huntington's Disease

Cardiac remodelling and contractile dysfunction occur during both acute and chronic disease processes including the accumulation of insoluble aggregates of misfolded amyloid proteins that are typical features of Alzheimer's, Parkinson's and Huntington's disease (HD). While HD has been...

Descripción completa

Detalles Bibliográficos
Autores principales:	Mielcarek, Michal, Inuabasi, Linda, Bondulich, Marie K., Muller, Thomas, Osborne, Georgina F., Franklin, Sophie A., Smith, Donna L., Neueder, Andreas, Rosinski, Jim, Rattray, Ivan, Protti, Andrea, Bates, Gillian P.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2014
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4125112/ https://www.ncbi.nlm.nih.gov/pubmed/25101683 http://dx.doi.org/10.1371/journal.pgen.1004550

Ejemplares similares

The Huntington's Disease-Related Cardiomyopathy Prevents a Hypertrophic Response in the R6/2 Mouse Model
por: Mielcarek, Michal, et al.
Publicado: (2014)

Myostatin inhibition prevents skeletal muscle pathophysiology in Huntington’s disease mice
por: Bondulich, Marie K., et al.
Publicado: (2017)

A common gene expression signature in Huntington’s disease patient brain regions
por: Neueder, Andreas, et al.
Publicado: (2014)

HDAC4 Does Not Act as a Protein Deacetylase in the Postnatal Murine Brain In Vivo
por: Mielcarek, Michal, et al.
Publicado: (2013)

SAHA Decreases HDAC 2 and 4 Levels In Vivo and Improves Molecular Phenotypes in the R6/2 Mouse Model of Huntington's Disease
por: Mielcarek, Michal, et al.
Publicado: (2011)

HDAC4-Myogenin Axis As an Important Marker of HD-Related Skeletal Muscle Atrophy
por: Mielcarek, Michal, et al.
Publicado: (2015)

Ablation of kynurenine 3-monooxygenase rescues plasma inflammatory cytokine levels in the R6/2 mouse model of Huntington’s disease
por: Bondulich, Marie Katrin, et al.
Publicado: (2021)

Huntington's disease is a multi-system disorder
por: Mielcarek, Michal
Publicado: (2015)

Alternative processing of human HTT mRNA with implications for Huntington’s disease therapeutics
por: Fienko, Sandra, et al.
Publicado: (2022)

Silencing Srsf6 does not modulate incomplete splicing of the huntingtin gene in Huntington’s disease models
por: Mason, Michael A., et al.
Publicado: (2020)

Inhibition of tumour necrosis factor alpha in the R6/2 mouse model of Huntington’s disease by etanercept treatment
por: Pido-Lopez, Jeffrey, et al.
Publicado: (2019)

Phenotype onset in Huntington’s disease knock‐in mice is correlated with the incomplete splicing of the mutant huntingtin gene
por: Franich, Nicholas R., et al.
Publicado: (2019)

HSF1-dependent and -independent regulation of the mammalian in vivo heat shock response and its impairment in Huntington's disease mouse models
por: Neueder, Andreas, et al.
Publicado: (2017)

A shared mechanism of muscle wasting in cancer and Huntington’s disease
por: Mielcarek, Michal, et al.
Publicado: (2015)

Subcellular Localization And Formation Of Huntingtin Aggregates Correlates With Symptom Onset And Progression In A Huntington’S Disease Model
por: Landles, Christian, et al.
Publicado: (2020)

Skeletal muscle pathology in Huntington's disease
por: Zielonka, Daniel, et al.
Publicado: (2014)

The pathogenic exon 1 HTT protein is produced by incomplete splicing in Huntington’s disease patients
por: Neueder, Andreas, et al.
Publicado: (2017)

Genetic Knock-Down of HDAC7 Does Not Ameliorate Disease Pathogenesis in the R6/2 Mouse Model of Huntington's Disease
por: Benn, Caroline L., et al.
Publicado: (2009)

HDAC4 Reduction: A Novel Therapeutic Strategy to Target Cytoplasmic Huntingtin and Ameliorate Neurodegeneration
por: Mielcarek, Michal, et al.
Publicado: (2013)

Neuro-Cardio Mechanisms in Huntington’s Disease and Other Neurodegenerative Disorders
por: Critchley, Bethan J., et al.
Publicado: (2018)

Formation of Polyglutamine Inclusions in a Wide Range of Non-CNS Tissues in the HdhQ150 Knock-In Mouse Model of Huntington's Disease
por: Moffitt, Hilary, et al.
Publicado: (2009)

Transcriptional Signature of an Altered Purine Metabolism in the Skeletal Muscle of a Huntington's Disease Mouse Model
por: Mielcarek, Michal, et al.
Publicado: (2017)

Implantation of undifferentiated and pre-differentiated human neural stem cells in the R6/2 transgenic mouse model of Huntington’s disease
por: El-Akabawy, Gehan, et al.
Publicado: (2012)

An altered extracellular matrix–integrin interface contributes to Huntington’s disease-associated CNS dysfunction in glial and vascular cells
por: Hernandez, Sarah J, et al.
Publicado: (2022)

Ex vivo 100 μm isotropic diffusion MRI-based tractography of connectivity changes in the end-stage R6/2 mouse model of Huntington’s disease
por: Manivannan, Ashwinee, et al.
Publicado: (2023)

Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the R6/1 Mouse Model of Huntington’s Disease
por: Rattray, Ivan, et al.
Publicado: (2013)

Combining feature selection and shape analysis uncovers precise rules for miRNA regulation in Huntington’s disease mice
por: Mégret, Lucile, et al.
Publicado: (2020)

Correlations of Behavioral Deficits with Brain Pathology Assessed through Longitudinal MRI and Histopathology in the HdhQ150/Q150 Mouse Model of Huntington’s Disease
por: Rattray, Ivan, et al.
Publicado: (2017)

Novel Isoforms of Heat Shock Transcription Factor 1, HSF1γα and HSF1γβ, Regulate Chaperone Protein Gene Transcription
por: Neueder, Andreas, et al.
Publicado: (2014)

Nucleolar stress controls mutant Huntington toxicity and monitors Huntington’s disease progression
por: Sönmez, Aynur, et al.
Publicado: (2021)

The CNS and bladder dysfunction
por: Tadic, Stasa D., et al.
Publicado: (2012)

Olfactory Dysfunction in Huntington’s Disease
por: Patino, Jorge, et al.
Publicado: (2021)

Prevalence of Non-psychiatric Comorbidities in Pre-symptomatic and Symptomatic Huntington's Disease Gene Carriers in Poland
por: Zielonka, Daniel, et al.
Publicado: (2020)

Structural Abnormalities of the Optic Nerve and Retina in Huntington’s Disease Pre-Clinical and Clinical Settings
por: Mazur-Michałek, Iwona, et al.
Publicado: (2022)

Regulatory mechanisms of incomplete huntingtin mRNA splicing
por: Neueder, Andreas, et al.
Publicado: (2018)

Caspase-6 does not contribute to the proteolysis of mutant huntingtin in the HdhQ150 knock-in mouse model of Huntington’s disease
por: Landles, Christian, et al.
Publicado: (2012)

Corticostriatal Dysfunction in Huntington’s Disease: The Basics
por: Bunner, Kendra D., et al.
Publicado: (2016)

SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington’s Disease Mice
por: Tulino, Raffaella, et al.
Publicado: (2016)

Correction: SIRT1 Activity Is Linked to Its Brain Region-Specific Phosphorylation and Is Impaired in Huntington's Disease Mice
por: Tulino, Raffaella, et al.
Publicado: (2016)

Embryonic Mutant Huntingtin Aggregate Formation in Mouse Models of Huntington’s Disease
por: Osmand, Alexander P., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_ui0cre9jbh49he2b592klp2i63